skip to Main Content

Key Factors in CRO Selection

The University of the Sciences in Philadelphia and TTC, a drug development data company, have been conducting a multi-year study on the factors associated with improved speed and cost effectiveness in clinical studies.

The University of the Sciences in Philadelphia and TTC, a drug development data company, have been conducting a multi-year study on the factors associated with improved speed and cost effectiveness in clinical studies.

The study determined that the individual elements used to select CROs can be summarized within a set of five broad dimensions: Processes for Issue Identification and Resolution; the Specifics of Project Execution; Team Chemistry; CRO Experience; and CRO Capabilities. Read the full article here.

What are your thoughts on this topic? Join the discussion in the Optimizing Oncology Clinical Research group on LinkedIn.

VIEW THE ARTICLE

Sign up to
Canadian Oncology
Trial News

  • This field is for validation purposes and should be left unchanged.
Back To Top
×Close search
Search